MET and metastatic malignant neoplasm: Furge et al. in 2003 proved the role of c-Met in Ras-mediated tumorigenecity and metastasis and suggested that HGF-Met signal inhibitors may have important therapeutic value for the treatment of metastatic cancers [35].